Sanofi and Regeneron’s Dupixent shows consistent safety profile
5th September 2022 Uncategorised 0Study involving children aged six to 11 years with moderate-to-severe asthma reveals positive data
More: Sanofi and Regeneron’s Dupixent shows consistent safety profile
Source: News